ID
29868
Beschreibung
Study ID: 104864-201 Clinical Study ID: 104864/A201 Study Title: A Phase III, Open-Label, Multicenter, Randomized, Comparative Study of Topotecan, Ara-C and G-CSF (TAG) versus Idarubicin, Ara-C and G-CSF (IDAG) in MDS Patients with RAEB (High-Risk), RAEB-t or in Patients with AML from a Preceding Phase of MDS Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: topotecan Trade Name: hycamtin Study Indication: Myelodysplastic Syndrome https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs
Link
https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs
Stichworte
Versionen (1)
- 24.04.18 24.04.18 - Halim Ugurlu
Rechteinhaber
GSK
Hochgeladen am
24. April 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
GSK Study ID 104864-201 Serious Adverse Experience
Serious Adverse Experience (SAE)
- StudyEvent: ODM
Beschreibung
Serious Adverse Experience (SAE)
Alias
- UMLS CUI-1
- C1519255
Beschreibung
Person Reporting SAE
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0335038
- UMLS CUI [1,2]
- C1519255
Beschreibung
Serious Adverse Experience
Datentyp
text
Alias
- UMLS CUI [1]
- C1519255
Beschreibung
Reason(s) for considering this a serious AE
Datentyp
text
Alias
- UMLS CUI [1]
- C3828190
Beschreibung
Onset Data and Time
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0040223
Beschreibung
End Date and Time (if ongoing please leave blank)
Datentyp
datetime
Alias
- UMLS CUI [1]
- C2981425
Beschreibung
Outcome
Datentyp
text
Alias
- UMLS CUI [1]
- C1705586
Beschreibung
Experience Course
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Beschreibung
Common Toxicity Grade
Datentyp
text
Alias
- UMLS CUI [1]
- C2826262
Beschreibung
Action Taken with Respect to Investigational Drug
Datentyp
text
Alias
- UMLS CUI [1]
- C2826626
Beschreibung
SAE Abate
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C3853704
Beschreibung
Study medication reintroduced
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C3854006
- UMLS CUI [1,2]
- C0580673
Beschreibung
If Yes to study medication reintroduced (or dose increased)
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0034897
Beschreibung
Relationship to Investigational Drug
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0439849
- UMLS CUI [1,2]
- C3854006
Beschreibung
Assessment of SAE
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C1710056
Beschreibung
Corrective Therapy
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
Beschreibung
Withdrawn due to this specific SAE
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1519255
Beschreibung
Relevant Laboratory Data - Please provide relevant abnormal laboratory data below
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0027365
Beschreibung
Relevant Laboratory Data-Date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0011008
Beschreibung
Relevant Laboratory Data-Value
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0587081
Beschreibung
Relevant Laboratory Data-Units
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C1519795
Beschreibung
Relevant Laboratory Data-Normal Range
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0086715
Beschreibung
Remarks (Please provide a brief narrative description of the SAE, attaching extra pages eg. hospital discharge summary if necessary)
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0587081
- UMLS CUI [1,2]
- C1519255
- UMLS CUI [1,3]
- C0947611
Beschreibung
Additional Informations
Alias
- UMLS CUI-1
- C1546922
Beschreibung
Randomisation code broken at investigational site
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0034656
- UMLS CUI [1,2]
- C1272691
- UMLS CUI [1,3]
- C2825164
Beschreibung
Randomisation/Study Medication Number
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0034656
- UMLS CUI [1,2]
- C0237753
Beschreibung
Investigators Signature
Datentyp
text
Alias
- UMLS CUI [1]
- C2346576
Beschreibung
Investigators Signature Date
Datentyp
date
Alias
- UMLS CUI [1]
- C0807937
Beschreibung
Please PRINT name
Datentyp
text
Alias
- UMLS CUI [1]
- C2826892
Ähnliche Modelle
Serious Adverse Experience (SAE)
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C3853704 (UMLS CUI [1,2])
C0580673 (UMLS CUI [1,2])
C0034897 (UMLS CUI [1,2])
C3854006 (UMLS CUI [1,2])
C1710056 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0027365 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,2])
C0086715 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
C1272691 (UMLS CUI [1,2])
C2825164 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])